Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arwana Citramulia Tbk (ARNA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Arwana Citramulia Tbk
UBC Medical Indonesia Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Arwana Citramulia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Arwana Citramulia Tbk trades at Rp462 (market cap 3.32T, 814.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: Arwana Citramulia Tbk is far larger — about 6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 814.1K). Which is the better fit depends on your goals.

ARNALABS
Market Cap
3.32T556.95B
Volume
814.1K60.83M
Lot
8.14K608.34K
Turnover
368.09M10.26B
Average Price
452.14168.64
Value
368.09M10.26B
Indicative Equilibrium Price
462152
Indicative Equilibrium Volume
2614.52K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ARNA
View details
LABS
View details

About Arwana Citramulia Tbk

PT. Arwana Citramulia Tbk (the Company) was established under the name PT Arwana Citra Mulia based on the notarial deed No. 21 dated February 22, 1993 of Raden Santoso, as amended by notarial deeds No. 147 dated October 26, 1993 and No. 105 dated November 15, 1993 of Imam Santoso, S.H., which covered, among others, the change in the Company's name PT Arwana Citramulia.

Read more on ARNA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS